ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
A

ASCO 2022 on Platinum vs. Non-Platinum Chemo for Platinum-Resistant Ovarian Cancer: A Meta-Analysis

By ASCO 2022 Conference Coverage FEATURING Alexey Rumyantsev
By ASCO 2022 Conference Coverage FEATURING Alexey Rumyantsev
449 views
June 9, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy
GYN
14:34

ASCO 2022 CeNtuRIOn: Rucaparib With Nivo & Ipi in Relapsed Ovarian C…

ASCO 2022 Conference Coverage

M. Hall

162 views
07:16

ASCO 2022 Efficacy & Safety of Dostarlimab in dMMR Solid Tumors: The…

ASCO 2022 Conference Coverage

T. André

77 views
01:05

Lecture Summary - ASCO 2022 on Platinum vs. Non-Platinum Chemo for P…

ASCO 2022 Conference Coverage

A. Rumyantsev

12 views
04:38

ASCO 2022 on Platinum vs. Non-Platinum Chemo for Platinum-Resistant …

ASCO 2022 Conference Coverage

A. Rumyantsev

449 views